Azithromycin Attenuates Fibroblast Growth Factors Induced Vascular Endothelial Growth Factor Via p38MAPK Signaling in Human Airway Smooth Muscle Cells

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 331-339

  Willems Widyastuti, Anna ^a   Vanaudenaerde, Bart M ^a   Vos, Robin ^a   Dilisen, Ellen ^a   Verleden, Stijn E ^a   De Vleeschauwer, Stéphanie I ^a   Vaneylen, Annemie ^a   Mooi, Wolter J ^c   de Boer, Willem I ^b   Sharma, Hari S ^a,c   Verleden, Geert M ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Airway smooth muscle cell; Angiogenesis; Azithromycin; Fibroblast growth factor; Mitogen activated protein kinases; Vascular endothelial growth factor

Indexed keywords

AZITHROMYCIN; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN A;

ARTICLE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRACELLULAR SPACE; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TIME; TRACHEA;

AZITHROMYCIN; DEXAMETHASONE; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TIME FACTORS; TRACHEA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886589916     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9331-0     Document Type: Article

References (35)

1. Zanini, A., Chetta, A., Imperatori, A. S., Spanevello, A., & Olivieri, D. (2010). The role of the bronchial microvasculature in the airway remodeling in asthma and COPD. Respiratory Research, 11, 132.
2. Carmeliet, P. (2003). Angiogenesis in health and disease. Nature Medicine, 9(6), 653-660.
3. Hashimoto, M., Tanaka, H., & Abe, S. (2005). Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest, 127(3), 965-972.
4. Kranenburg, A. R., Willems-Widyastuti, A., Mooi, W. J., Saxena, P. R., Sterk, P. J., de Boer, W. I., et al. (2005). Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1. Journal of Pathology, 206(1), 28-38.
5. Kranenburg, A. R., de Boer, W. I., Alagappan, V. K., Sterk, P. J., & Sharma, H. S. (2005). Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax, 60(2), 106-113.
6. Walters, E. H., Reid, D., Soltani, A., & Ward, C. (2008). Angiogenesis: A potentially critical part of remodeling in chronic airway diseases? Pharmacology and Therapeutics, 118(1), 128-137.
7. Kanazawa, H., Asai, K., Hirata, K., & Yoshikawa, J. (2003). Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. American Journal of Medicine, 114(5), 354-358.
8. Feltis, B. N., Wignarajah, D., Zheng, L., Ward, C., Reid, D., Harding, R., et al. (2006). Increased vascular endothelial growth factor and receptors: Relationship to angiogenesis in asthma. American Journal of Respiratory and Critical Care Medicine, 173(11), 1201-1207.
9. Ferrara, N. (2004). Vascular endothelial growth factor: Basic science and clinical progress. Endocrine Reviews, 25(4), 581-611.
10. Alagappan, V. K., McKay, S., Widyastuti, A., Garrelds, I. M., Bogers, A. J., Hoogsteden, H. C., et al. (2005). Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochemistry and Biophysics, 43(1), 119-129.
11. Hoshino, M., Takahashi, M., & Aoike, N. (2001). Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. Journal of Allergy and Clinical Immunology, 107(2), 295-301.
12. Shute, J. K., Solic, N., Shimizu, J., McConnell, W., Redington, A. E., & Howarth, P. H. (2004). Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax, 59(7), 557-562.
13. Buczek-Thomas, J. A., Lucey, E. C., Stone, P. J., Chu, C. L., Rich, C. B., Carreras, I., et al. (2004). Elastase mediates the release of growth factors from lung in vivo. American Journal of Respiratory Cell and Molecular Biology, 31(3), 344-350.
14. Duarte, M., Kolev, V., Soldi, R., Kirov, A., Graziani, I., Oliveira, S. M., et al. (2006). Thrombin induces rapid PAR1-mediated non-classical FGF1 release. Biochemical and Biophysical Research Communications, 350(3), 604-609.
15. Friesel, R. E., & Maciag, T. (1995). Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. The FASEB Journal, 9(10), 919-925.
16. Kanazawa, H., & Yoshikawa, T. (2007). Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest, 132(4), 1169-1174.
17. Shao, M. X., & Nadel, J. A. (2005). Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. Journal of Immunology, 175(6), 4009-4016.
18. Feltis, B. N., Wignarajah, D., Reid, D. W., Ward, C., Harding, R., & Walters, E. H. (2007). Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax, 62(4), 314-319.
19. Zanini, A., Chetta, A., Saetta, M., Baraldo, S., Castagnetti, C., Nicolini, G., et al. (2009). Bronchial vascular remodeling in patients with COPD and its relationship with inhaled steroid treatment. Thorax, 64(12), 1019-1024.
20. Chung, K. F., Caramori, G., & Adcock, I. M. (2009). Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: Present and future. European Journal of Clinical Pharmacology, 65(9), 853-871.
21. Marwick, J. A., Kirkham, P. A., Stevenson, C. S., Danahay, H., Giddings, J., Butler, K., et al. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. American Journal of Respiratory Cell and Molecular Biology, 31(6), 633-642.
22. Vanaudenaerde, B. M., Wuyts, W. A., Geudens, N., Dupont, L. J., Schoofs, K., Smeets, S., et al. (2007). Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. American Journal of Transplantation, 7(1), 76-82.
23. Seemungal, T. A., Wilkinson, T. M., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008). Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. American Journal of Respiratory and Critical Care Medicine, 178(11), 1139-1147.
24. Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J., & Gibson, P. G. (2008). Clarithromycin targets neutrophilic airway inflammation in refractory asthma. American Journal of Respiratory and Critical Care Medicine, 177(2), 148-155.
25. Wang, X. F., Cui, J. Z., Prasad, S. S., & Matsubara, J. A. (2005). Altered gene expression of angiogenic factors induced by calcium-mediated dissociation of retinal pigment epithelial cells. Investigative Ophthalmology & Visual Science, 46(4), 1508-1515.
26. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., & Mathieu, C. (2001). An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods, 25(4), 386-401.
27. Redington, A. E., Roche, W. R., Madden, J., Frew, A. J., Djukanovic, R., Holgate, S. T., et al. (2001). Basic fibroblast growth factor in asthma: Measurement in bronchoalveolar lavage fluid basally and following allergen challenge. Journal of Allergy and Clinical Immunology, 107(2), 384-387.
28. Wang, J. K., Gao, G., & Goldfarb, M. (1994). Fibroblast growth factor receptors have different signaling and mitogenic potentials. Molecular and Cellular Biology, 14(1), 181-188.
29. Ma, J. Y., Medicherla, S., Kerr, I., Mangadu, R., Protter, A. A., & Higgins, L. S. (2008). Selective p38alpha mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma. Journal of Asthma and Allergy, 1, 31-44.
30. Williams, A. S., Issa, R., Durham, A., Leung, S. Y., Kapoun, A., Medicherla, S., et al. (2008). Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation. European Journal of Pharmacology, 600(1-3), 117-122.
31. Volpi, G., Facchinetti, F., Moretto, N., Civelli, M., & Patacchini, R. (2011). Cigarette smoke and alpha, beta-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. British Journal of Pharmacology, 163(3), 649-661.
32. Rovina, N., Papapetropoulos, A., Kollintza, A., Michailidou, M., Simoes, D. C., Roussos, C., et al. (2007). Vascular endothelial growth factor: An angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respiratory Research, 8, 53.
33. Clark, A. R., Martins, J. R., & Tchen, C. R. (2008). Role of dual specificity phosphatases in biological responses to glucocorticoids. Journal of Biological Chemistry, 283(38), 25765-25769.
34. Vos, R., Vanaudenaerde, B. M., Verleden, S. E., De Vleeschauwer, S. I., Willems-Widyastuti, A., van Raemdonck, D. E., et al. (2011). A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. European Respiratory Journal, 37(1), 164-172.
35. Verleden, G. M., Vanaudenaerde, B. M., Dupont, L. J., & van Raemdonck, D. E. (2006). Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. American Journal of Respiratory and Critical Care Medicine, 174(5), 566-570.